Mar 07, 2023 / 07:10PM GMT
Troy Langford - TD Cowen - Analyst
It's my pleasure today to introduce Lisa Anson, CEO of Redx Pharma, who's going to give a corporate update. Take it away, Lisa.
Lisa Anson - Redx Pharma plc - CEO
Great. Thanks, Troy. Hi, everyone. Thanks for coming to join us. It's a real pleasure to talk you through the Redx Pharma's story.
Obviously, this presentation has the usual disclaimers and forward-looking statements that I'm sure you've all heard about many times already. My name is Lisa Anson, I'm the CEO of REdx. It's been my pleasure to lead the company for the last three years. We've been through a real growth trajectory. With me today is Pete Collum, our CFO, who will talk through in a moment.
We have a really strong management team. It's one of the great things about Redx. The other members of the team not here today, Richard Armer, our CSO; and Jane Robertson, our CMO. And together, we've really been driving our product forward over the last three years.
For those of you who don't know Redx at all. We're a small molecule company
Redx Pharma PLC at Cowen Health Care Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot